Adiponectin protects against development of metabolic disturbances in a PCOS mouse model
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Significance: Women with polycystic ovary syndrome (PCOS) have reduced fertility and increased risk of developing type 2 diabetes. Adiponectin, an adipocyte-derived hormone, together with adipocyte size, is the strongest factor associated with insulin resistance in PCOS. The potential causal relationship among adiponectin levels, infertility, and metabolic dysfunction in PCOS is, however, unknown. Exploiting mouse models, we found that adiponectin is indeed involved in PCOS-related insulin resistance, and, albeit to a much smaller extent, is also involved in the development of reproductive dysfunction. Thus, increased levels of adiponectin can prevent prepubertal androgen-induced metabolic dysfunction in dihydrotestosterone-exposed mice with PCOS-like traits. Collectively, our findings support the notion that altered adipose tissue functionality is a key mediator of metabolic dysfunction in women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824 · cited 1×
“Adiponectin is an adipocyte-derived hormone exerting potent positive effects on whole-body insulin sensitivity (10, 11), as well as on pancreatic beta-cell survival and functionality (12–14).”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“High levels of circulating androgens and insulin resistance are hallmarks of PCOS and increase the risk of women with PCOS developing type 2 diabetes (25).”
BackgroundLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“Indeed, it has been demonstrated that 30–40% of women with PCOS have impaired glucose tolerance, and as many as 10% develop diabetes by the age of 40 y (3, 4).”
BackgroundTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · cited 2×
“PCOS is one of the leading causes of poor fertility and is associated with abdominal obesity, metabolic syndrome, and an increased risk of developing type 2 diabetes (1, 2).”
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“Furthermore, overexpression of adiponectin is associated with improved whole-body insulin sensitivity and profound positive effects within adipose tissue, such as increased mitochondrial density in adipocytes, smaller adipocyte size, and transcriptional up-regulation of factors involved in lipid storage through effici…”
BackgroundPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 1×
“Indeed, it has been demonstrated that 30–40% of women with PCOS have impaired glucose tolerance, and as many as 10% develop diabetes by the age of 40 y (3, 4).”
BackgroundReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782 · cited 2×
“The first genome-wide association studies on Han Chinese populations identified more than 10 susceptibility loci for PCOS, including RAB5B (34, 35).”
BackgroundGLUT2, glucose sensing and glucose homeostasis
Thorens, B. (2015) · Diabetologia · doi:10.1007/s00125-014-3451-1 · Cited by 722 · cited 1×
“GLUT2, which is expressed at a relatively low level, is not a primary factor for glucose-stimulated insulin secretion in human beta cells, since they mainly rely on GLUT1 and GLUT3 (47).”
BackgroundGenome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678 · cited 2×
“The first genome-wide association studies on Han Chinese populations identified more than 10 susceptibility loci for PCOS, including RAB5B (34, 35).”
BackgroundCombs, T. P., Pajvani, U. B., Berg, A. H., Lin, Y., Jelicks, L. A., Laplante, M., Nawrocki, A. R., Rajala, M. W., Parlow, A. F., Cheeseboro, L., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1068 · Cited by 545 · cited 1×
“WT, APNtg, and APNko mice, on a C57BL/6J background (15, 57), were bred and maintained under standard housing conditions.”
MethodMannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., Hellström, M., Lönn, L., Olivecrona, G., Stener-Victorin, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1290 · Cited by 369 · cited 3×
“Reduced adiponectin levels may be one possible mechanism responsible for decreased insulin sensitivity in women with PCOS (8).”
BackgroundSingh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., & Bhasin, S. (2006) · Endocrinology · doi:10.1210/en.2004-1649 · Cited by 369
Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis
Toulis, K. A., Goulis, D. G., Farmakiotis, D., Georgopoulos, N. A., Katsikis, I., Tarlatzis, B. C., Papadimas, I., & Panidis, D. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp006 · Cited by 262 · cited 1×
“Research has shown that low circulating adiponectin (8, 29), together with increased waist circumference and enlarged adipocyte size (8, 30, 31), may explain insulin resistance in women with PCOS.”
BackgroundAdiponectin, driver or passenger on the road to insulin sensitivity?
Ye, R., & Scherer, P. E. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.04.001 · Cited by 251 · cited 1×
“Adiponectin is an adipocyte-derived hormone exerting potent positive effects on whole-body insulin sensitivity (10, 11), as well as on pancreatic beta-cell survival and functionality (12–14).”
BackgroundDumesic, D. A., Akopians, A. L., Madrigal, V. K., Ramirez, E., Margolis, D. J., Sarma, M. K., Thomas, A. M., Grogan, T. R., Haykal, R., Schooler, T. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2586 · Cited by 222 · cited 2×
“Hyperandrogenism is associated with intra-abdominal fat deposition in lean women with PCOS (9).”
BackgroundEstrogen suppresses transcription of lipoprotein lipase gene
Homma, H., Kurachi, H., Nishio, Y., Takeda, T., Yamamoto, T., Adachi, K., Morishige, K.-I., Ohmichi, M., Matsuzawa, Y., & Murata, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11404 · Cited by 209
Enhanced metabolic flexibility associated with elevated adiponectin levels
Asterholm, I. W., & Scherer, P. E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090647 · Cited by 157 · cited 2×
“In line with our previous study (16), we found a trend toward smaller adipocytes in APNtg compared with WT in the placebo group (P = 0.”
BackgroundResultSelf-citationEpigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
Kokosar, M., Benrick, A., Perfilyev, A., Fornes, R., Nilsson, E., Maliqueo, M., Behre, C. J., Sazonova, A., Ohlsson, C., Ling, C., et al. (2016) · Scientific Reports · doi:10.1038/srep22883 · Cited by 137 · cited 3×
“PPARγ and IRS1 are type 2 diabetes susceptibility genes, and gene expression is decreased in adipose tissue in women with PCOS (5, 33).”
BackgroundSelf-citation
Research works printed but not linked: 42
- A Corbould, Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: Are the molecular mechanisms distinct from type 2 diabetes? Panminerva Med 50, 279–294 (2008).
- 10.4161/adip.28731 · DOI · Paper page
- 10.1210/jc.2006-1665 · DOI · Paper page
- 10.1210/jc.2011-2377 · DOI · Paper page
- 10.1016/j.peptides.2010.02.004 · DOI
- 10.1111/j.1463-1326.2012.01626.x · DOI · Paper page
- 10.1074/jbc.M505311200 · DOI · Paper page
- 10.1016/B978-0-12-398313-8.00010-5 · DOI
- 10.1016/j.mce.2015.04.026 · DOI
- 10.1155/2013/964070 · DOI
- 10.1371/journal.pone.0080416 · DOI · Paper page
- 10.1093/molehr/gav025 · DOI
- 10.1210/en.2011-1754 · DOI · Paper page
- 10.1210/en.2007-0168 · DOI · Paper page
- 10.1016/j.fertnstert.2007.03.085 · DOI
- I Ek, P Arner, A Bergqvist, K Carlström, H Wahrenberg, Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: A possible link to insulin resistance? J Clin Endocrinol Metab 82, 1147–1153 (1997).
- 10.1016/j.steroids.2013.05.001 · DOI · Paper page
- 10.1016/0026-0495(89)90198-4 · DOI · Paper page
- 10.1055/s-2007-1009245 · DOI · Paper page
- 10.1016/j.rbmo.2009.05.003 · DOI
- 10.1152/ajpendo.90731.2008 · DOI · Paper page
- 10.1677/joe.0.1610089 · DOI
- 10.1016/S0960-0760(03)00231-0 · DOI
- 10.1073/pnas.1523236113 · DOI · Paper page
- 10.1210/en.2011-1339 · DOI
- 10.1042/BJ20141455 · DOI
- 10.1007/s11154-013-9280-6 · DOI · Paper page
- 10.1172/JCI115858 · DOI · Paper page
- 10.1007/BF00200660 · DOI
- 10.1016/S0006-291X(02)00913-0 · doi:10.1016/s0006-291x(02)00913-0
- 10.1097/00126334-200212150-00009 · DOI
- 10.1210/en.2011-1754 · DOI · Paper page
- 10.1210/en.2014-1196 · DOI · Paper page
- 10.1055/s-0034-1371090 · DOI
- 10.1095/biolreprod.115.131631 · DOI · Paper page
- 10.1210/en.2012-1693 · DOI
- 10.2337/db07-0275 · DOI · Paper page
- 10.1155/2014/957076 · DOI
- 10.1038/oby.2000.47 · DOI · Paper page
- 10.1152/ajpendo.00078.2012 · DOI
- 10.1152/ajpendo.00421.2012 · DOI · Paper page
- 10.1210/jc.2009-1908 · DOI · Paper page
Cited by
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Prenatal Androgen Exposure and Transgenerational Susceptibility to Polycystic Ovary Syndrome
Risal, S., Pei, Y., Lu, H., Manti, M., Fornes, R., Pui, H.-P., Zhao, Z., Massart, J., Ohlsson, C., Lindgren, E., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0666-1 · Cited by 356
Self-citationAnimal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Self-citationHyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
Wang, J., Wu, D., Guo, H., & Li, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116940 · Cited by 322
Metadata
- Authors
- Benrick, A., Chanclón, B., Micallef, P., Wu, Y., Hadi, L., Shelton, J. M., Stener-Victorin, E., & Wernstedt Asterholm, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-08-08
- Volume
- 114
- Issue
- 34
- Pages
- E7187-E7196
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2742716416
- Cited by
- 137
- References
- 20
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Vetenskapsrådet (2012-1601, 2013-7107, 2014-2775)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.